TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
▌TickerSpark Feed

OMER coverage

Every article, report, and earnings note where OMER appears.

Omeros Corporation (OMER) slips despite deep earnings beat
Earnings AnalysisOMER

Omeros Corporation (OMER) slips despite deep earnings beat

Omeros Corporation (OMER) beat third-quarter EPS estimates, but shares slipped as a large GAAP loss and derivative mark-to-market charge overshadowed the results. This deep-dive analysis looks beyond the headline to Yartemlia growth, reimbursement progress, and what the quarter may signal for 2027.

Nov 17, 2026·7 MIN
HealthcareBiotechnology
Omeros (OMER): YARTEMLEA Launch Drives a Buy Case
Research ReportOMER

Omeros (OMER): YARTEMLEA Launch Drives a Buy Case

Omeros is transitioning from a development story to a commercial biotech as YARTEMLEA ramps quickly, but the stock still carries meaningful balance-sheet and execution risk. The launch momentum and improving cash flow support a Buy rating despite volatile GAAP results.

Nov 16, 2026·22 MIN
HealthcareBiotechnologyBiotech
Omeros Corporation (OMER) falls after earnings beats
Earnings FlashOMER

Omeros Corporation (OMER) falls after earnings beats

Omeros Corporation (OMER) falls 14.6% as investors react to earnings beats, with shares under pressure despite the company topping expectations.

Nov 16, 2026·2 MIN
HealthcareBiotechnology
▌On-Demand Research

Want a deeper dive on OMER?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate OMER Report
▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌For Active Investors

Stock research for every investor

  • Reports on any stock
  • Daily market intelligence
  • AI analyst in your pocket
  • Portfolio analysis tools
Get Full Access →

Cancel anytime

▌Today's Top MoverGPN
▲9.95%
Global Payments Inc. · $91.83

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA